Idiopathic CK-elevation;Idiopathische CK-erhöhung

Nervenheilkunde

Volumn 25, Issue 7, 2006, Pages 577-578

  Müller Felber, Wolfgang ^a   Schoser, B ^a   Pongratz, D ^a   Lehmann Horn, F ^b   Reimers, C D ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Diakonieanstalt Flensburg   (Germany)

Author keywords

CK elevation; Malignant hyperthermia; Myopathy

Indexed keywords

CREATINE KINASE;

ARTICLE; DISEASE PREDISPOSITION; ENZYME METABOLISM; HUMAN; MALIGNANT HYPERTHERMIA; NEUROMUSCULAR DISEASE;

EID: 33846615528     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1626754     Document Type: Article

References (8)

1. Carbone I et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000; 54: 1373-6.
2. Bruno C, Bertini E, Santorelli FM, DiMauro S. HyperCKemia as the only sign of McArdle's disease in a child. J Child Neurol 2000; 15: 137-8.
3. Prelle A et al. Asymptomatic familial hyperCKemia associated with desmin accumulation in skeletal muscle. J Neurol Sci 1996; 140: 132-6.
4. Brewster LM, de Visser M. Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol Scand 1988; 77: 60-3.
5. Prelle A et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002; 249: 305-11.
6. Kleppe B et al. Findings in 100 patients with idiopathic increase in serum creatine kinase activity. Med Klin 1995; 90: 623-7.
7. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997; 84: 1038-41.
8. Paasuke RT, Brownell AK. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. JAMA 1986; 255: 769-71.